seed
Stage
2017
Founded
2
Investors
About
Accure Therapeutics is a pharmaceutical R&D company developing clinical-stage drug candidates to treat central nervous system disorders such as Parkinson’s disease and post-traumatic epilepsy, supported by public and foundation grants.
Explore Accure Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.